Explore
Trendline
Faruqi Faruqi, LLP Investigates Immutep Over Securities Class Action Following Trial Discontinuation
Faruqi Faruqi, LLP Investigates Immutep Over Securities Class Action Following Trial Discontinuation
Read More
Trendline
Northwest Biotherapeutics Reports Q1 2026 Financial Results with Revenue Increase
Northwest Biotherapeutics Reports Q1 2026 Financial Results with Revenue Increase
Read More
Trendline
Brainstorm Cell Therapeutics Reports Narrowed Loss in Q1 2026 Amid Clinical Developments
Brainstorm Cell Therapeutics Reports Narrowed Loss in Q1 2026 Amid Clinical Developments
Read More
Trendline
Nanoviricides Reports Third Quarter Loss Amid Clinical Advancements
Nanoviricides Reports Third Quarter Loss Amid Clinical Advancements
Read More
Trendline
Edesa Biotech Reports Increased Net Loss Amid R and Manufacturing Expansion
Edesa Biotech Reports Increased Net Loss Amid R and Manufacturing Expansion
Read More
Trendline
Power Solutions International Faces Class Action Lawsuit Over Securities Fraud Allegations
Power Solutions International Faces Class Action Lawsuit Over Securities Fraud Allegations
Read More
Trendline
Inhibrx Reports First Quarter 2026 Financial Results Highlighting Clinical Progress
Inhibrx Reports First Quarter 2026 Financial Results Highlighting Clinical Progress
Read More
Trendline
Pomerantz Law Firm Files Class Action Against Graphic Packaging Holding Company Over Securities Violations
Pomerantz Law Firm Files Class Action Against Graphic Packaging Holding Company Over Securities Violations
Read More
Trendline
Innate Pharma Reports Progress in Immunotherapy Pipeline and Financial Results for Q1 2026
Innate Pharma Reports Progress in Immunotherapy Pipeline and Financial Results for Q1 2026
Read More
Trendline
Perspective Therapeutics Advances VMT-α-NET with High Response Rates and Manufacturing Expansion
Perspective Therapeutics Advances VMT-α-NET with High Response Rates and Manufacturing Expansion
Read More
Trendline
Robbins Geller Rudman Dowd LLP Launches Investigation into Via Transportation for Potential Securities Violations
Robbins Geller Rudman Dowd LLP Launches Investigation into Via Transportation for Potential Securities Violations
Read More
Trendline
Palatin Technologies Reports Q3 2026 Financial Results and Business Progress
Palatin Technologies Reports Q3 2026 Financial Results and Business Progress
Read More